From the subgroup analyses, the most favorable outcomes, in terms of survival, were especially noted among those with a significant tumor burden, as evidenced by the presence of PVTT, AFP levels ≥ 400 ng/mL, ≥3 intrahepatic lesions, and a main tumor size ≥ 5 cm. The gene discussed is AFP; the disease is neoplasm.